Thyroid: Biological actions of 'nonclassical' thyroid hormones

Journal of Endocrinology

Volumn 221, Issue 2, 2014, Pages

  Senese, Rosalba ^a   Cioffi, Federica ^b   De Lange, Pieter ^a   Goglia, Fernando ^b   Lanni, Antonia ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

Author keywords

Nongenomic effects; Thyroid hormone; Thyroid hormone metabolism; Thyroid hormone receptors

Indexed keywords

CALCIUM; CYTOCHROME C OXIDASE; DIIODOTHYRONINE; HOMODIMER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INTEGRIN RECEPTOR; LIOTHYRONINE; NONCLASSICAL THYROID HORMONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C FOS; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TETRAIODOTHYROACETIC ACID; THYROID HORMONE; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; THYRONAMINE; TIRATRICOL; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; 3,3',5' TRIIODOTHYRONINE; 3,3',5-TRIIODOTHYROACETIC ACID; 3,5-DIIODOTHYRONINE; THYRONINE DERIVATIVE; THYROXINE;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; CONFORMATIONAL TRANSITION; CYTOPLASM; DEACETYLATION; DIMERIZATION; DNA BINDING MOTIF; ENERGY EXPENDITURE; ENZYME ACTIVATION; ENZYME REGULATION; HORMONE ACTION; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RESTING METABOLIC RATE; SECOND MESSENGER; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSACTIVATION; ANALOGS AND DERIVATIVES; ANIMAL; METABOLISM; PHYSIOLOGY; THYROID GLAND;

ANIMALS; DIIODOTHYRONINES; HUMANS; SIGNAL TRANSDUCTION; THYROID GLAND; THYROID HORMONES; THYRONINES; THYROXINE; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 84899834093     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0573     Document Type: Article

References (120)

1. Ackermans MT, Klieverik LP, Ringeling P, Endert E, Kalsbeek A&Fliers E 2010 An online solid-phase extraction-liquid chromatography-tandem mass spectrometry method to study the presence of thyronamines in plasma and tissue and their putative conversion from 13C6-thyroxine. Journal of Endocrinology 206 327-334. (doi:10.1677/JOE-10-0060)
2. Alisi A, Spagnuolo S, Napoletano S, Spaziani A&Leoni S 2004 Thyroid hormones regulate DNA-synthesis and cell-cycle proteins by activation of PKCa and p42/44 MAPK in chick embryo hepatocytes. Journal of Cellular Physiology 201 259-265. (doi:10.1002/jcp.20060)
3. Angelin B&Rudling M 2010 Lipid lowering with thyroid hormone and thyromimetics. Current Opinion in Lipidology 21 499-506. (doi:10.1097/MOL.0b013e3283402e9c)
4. Antonelli A, Fallahi P, Ferrari SM, DiDomenicantonio A, MorenoM, LanniA & Goglia F 2011 3,5-Diiodo-L-thyronine increases restingmetabolic rate and reduces body weight without undesirable side effects. Journal of Biological Regulators and Homeostatic Agents 25 655-660.
5. Anzai R, Adachi M, Sho N, Muroya K, Asakura Y&Onigata K 2012 Long-term 3,5,30 triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations. Thyroid 22 1069-1075. (doi:10.1089/thy.2011.0450)
6. Araki O, Ying H, Zhu XG, Willingham MC&Cheng SY 2009 Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. Molecular Endocrinology 23 308-315. (doi:10.1210/me.2008-0311)
7. Arnold S, Goglia F&Kadenbach B 1998 3,5-Diiodothyronine binds to subunit Va of cytochrome-c oxidase and abolishes the allosteric inhibition of respiration by ATP. European Journal of Biochemistry 252 325-323. (doi:10.1046/j.1432-1327.1998.2520325.x)
8. Ball SG, Sokolov J&Chin WW 1997 3,5-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro. Journal of Molecular Endocrinology 19 137-147. (doi:10.1677/jme.0.0190137)
9. Bassett JH, Harvey CB&Williams GR 2003 Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Molecular and Cellular Endocrinology 213 1-11. (doi:10.1016/j.mce.2003.10.033)
10. Baur A, Bauer K, Jarry H&Koehrle J 1997 3,5-Diiodo-L-thyronine stimulates type 1 50deiodinase activity in rat anterior pituitaries in vivo and in reaggregate cultures and GH3 cells in vitro. Endocrinology 138 3242-3248. (doi:10.1210/endo.138.8.5333)
11. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S&Davis P 2005 Integrin aVb3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146 2864-2871. (doi:10.1210/en.2005-0102)
12. Bianco AC 2011 Minireview: cracking the metabolic code for thyroid hormone signaling. Endocrinology 152 3306-3311. (doi:10.1210/en.2011-1104)
13. Bobek S, Sechman A, Niezgoda J&Jacek T 2002 Reverse 3,30,50-triiodothyronine suppresses increase in free fatty acids in chickens elicited by dexamethasone or adrenaline. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine 49 121-124. (doi:10.1046/j.1439-0442.2002.00343.x)
14. Bogazzi F, Hudson LD&Nikodem VM 1994 A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator activated receptor. Journal of Biological Chemistry 269 11683-11686.
15. BraccoD, MorinO, SchutzY, Liang H, JequierE&Burger AG 1993 Comparison of the metabolic and endocrine effects of 3,5,30-triiodothyroacetic acid and thyroxine. Journal of Clinical Endocrinology and Metabolism 77 221-228. (doi:10.1210/jcem.77.1.8325946)
16. Braulke LJ, Klingenspor M, DeBarber A, Tobias SC, Grandy DK, Scanlan TS & Heldmaier G 2008 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology 178 167-177. (doi:10.1007/s00360-007-0208-x)
17. Cable EE, Finn PD, Stebbins JW, Hou J, Ito BR, van Poelje PD, Linemeyer DL & Erion MD 2009 Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology 49 407-417.
18. Cavallo A, Gnoni A, Conte E, Siculella L, Zanotti F, Papa S&Gnoni GV 2011 3,5-Diiodo-L-thyronine increases FoF1-ATP synthase activity and cardiolipin level in liver mitochondria of hypothyroid rats. Journal of Bioenergetics and Biomembranes 43 349-357. (doi:10.1007/s10863-011-9366-3)
19. Cheng SY, Leonard JL&Davis PJ 2010 Molecular aspects of thyroid hormone actions. Endocrine Reviews 31 139-170. (doi:10.1210/er.2009-0007)
20. Cheng SY 2000 Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Reviews in Endocrine and Metabolic Disorders 1 9-18.
21. Chiellini G, Apriletti JW, Yoshihara HA, Baxter JD, Ribeiro RC&Scanlan TS 1998 A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chemistry&Biology 5 299-306. (doi:10.1016/S1074-5521(98)90168-5)
22. Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, DeBarber A, Brogioni S, Ronca-Testoni S, CerbaiE, GrandyDKet al. 2007 Cardiac effects of 3-iodothyronamine: a new aminergic systemmodulating cardiac function. FASEB Journal 21 1597-1608. (doi:10.1096/fj.06-7474com)
23. Cioffi F, Zambad SP, Chhipa L, Senese R, Busiello RA, Tuli D, Munshi S, Moreno M, Lombardi A, Gupta RC et al. 2010 TRC150094, a novel functional analog of iodothyronines, reduces adiposity by increasing energy expenditure and fatty acid oxidation in rats receiving a high-fat diet. FASEB Journal 24 3451-3461. (doi:10.1096/fj.10-157115)
24. Cioffi F, Senese R, Lanni A&Goglia F 2013 Thyroid hormones and mitochondria: with a brief look at derivatives and analogues. Molecular and Cellular Endocrinology 379 51-61. (doi:10.1016/j.mce.2013.06.006)
25. Cody V, Davis PJ&Davis FB 2007 Molecular modeling of the thyroid hormone interactions with avb3 integrin. Steroids 72 165-170. (doi:10.1016/j.steroids.2006.11.008)
26. DeBarber AE, Geraci T, Colasurdo VP, Hackenmueller SA&Scanlan TS 2008 Validation of a liquid chromatography-tandem mass spectrometry method to enable quantification of 3-iodothyronamine from serum. Journal of Chromatography. A 1210 55-59. (doi:10.1016/j.chroma.2008.09.022)
27. De Lange P, Senese R, Cioffi F, Moreno M, Lombardi A, Silvestri E, Goglia F & Lanni A 2008 Rapid activation by 3,5,30-L-triiodothyronine of adenosine 50-monophosphate-activated protein kinase/acetylcoenzyme a carboxylase and akt/protein kinase B signaling pathways: relation to changes in fuel metabolism and myosin heavy-chain protein content in rat gastrocnemius muscle in vivo. Endocrinology 149 6462-6470. (doi:10.1210/en.2008-0202)
28. De Lange P, Cioffi F, Senese R, Moreno M, Lombardi A, Silvestri E, De Matteis R, Lionetti L, Mollica MP, Goglia F et al. 2011 Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-L-thyronine in rats. Diabetes 60 2730-2739. (doi:10.2337/db11-0207)
29. 2) in pituitary GH3 cells. American Journal of Physiology. Endocrinology and Metabolism 302 E1419-E1430. (doi:10.1152/ajpendo.00389.2011)
30. Dumas P, Autissier N, Loireau A&Michel R 1982 Effects of 3,5,30-triiodothyroacetic acid (TRIAC) on protein metabolism of genetically obese or non-obese Zucker rats. Comptes Rendus des Séances de la Société de Biologie et de Ses Filiales 176 178-183.
31. Farwell AP, Lynch RM, Okulicz WC, Comi AM&Leonard JL 1990 The actin cytoskeleton mediates the hormonally regulated translocation of type II iodothyronine 50-deiodinase in astrocytes. Journal of Biological Chemistry 265 18546-18553.
32. Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ&Leonard JL 2006 Dynamic nongenomic actions of thyroid hormone in the developing rat brain. Endocrinology 147 2567-2574. (doi:10.1210/en.2005-1272)
33. Flamant F&Samarut J 2003 Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends in Endocrinology and Metabolism 14 85-90. (doi:10.1016/S1043-2760(02)00043-7)
34. Forman BM, Casanova J, Raaka BM, Ghysdael J&Samuels HH 1992 Halfsite spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Molecular Endocrinology 6 429-442. (doi:10.1210/mend.6.3.1316541)
35. Frascarelli S, Ghelardoni S, Chiellini G, Vargiu R, Ronca-Testoni S, Scanlan TS, Grandy DK&Zucchi R 2008 Cardiac effects of trace amines: pharmacological characterization of trace amine associated receptors. European Journal of Pharmacology 587 231-236. (doi:10.1016/j.ejphar.2008.03.055)
36. 2+)-adenosine triphosphatase from rat erythrocyte. Journal of Biological Chemistry 256 7113-7114.
37. García GC, Jeziorski MC, Valverde RC&Orozco A 2004 Effects of iodothyronines on the hepatic outer-ring deiodinating pathway in killifish. General and Comparative Endocrinology 135 201-209. (doi:10.1016/j.ygcen.2003.09.010)
38. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z&Puigserver P 2007 Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO Journal 26 1913-1923.
39. Gnoni GV, Rochira A, Leone A, Damiano F, Marsigliante S&Siculella L 2012 3,5,3'triiodo-L-thyronine induces SREBP-1 expression by nongenomic actions in human HEP G2 cells. Journal of Cellular Physiology 227 2388-2397.
40. Goglia F 2005 Biological effects of 3,5-diiodothyronine (T2). Biochemistry 70 164-172.
41. Goglia F, Lanni A, Barth J&Kadenbach B 1994 Interaction of diiodothyronines with isolated cytochrome c oxidase. FEBS Letters 346 295-298. (doi:10.1016/0014-5793(94)00476-5)
42. Goldberg IJ, Huang LS, Huggins LA, Yu S, Nagareddy PR, Scanlan TS & Ehrenkranz JR 2012 Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway. Endocrinology 153 5143-5149. (doi:10.1210/en.2012-1572)
43. Grasselli E, Voci A, Canesi L, De Matteis R, Goglia F, Cioffi F, Fugassa E, Gallo G&Vergani L 2011a Direct effects of iodothyronines on excess fat storage in rat hepatocytes. Journal of Hepatology 54 1230-1236. (doi:10.1016/j.jhep.2010.09.027)
44. Grasselli E, Voci A, Canesi L, Goglia F, Ravera S, Panfoli I, Gallo G & Vergani L 2011b Non-receptor-mediated actions are responsible for the lipid-lowering effects of iodothyronines in FaO rat hepatoma cells. Journal of Endocrinology 21 59-69. (doi:10.1530/JOE-11-0074)
45. Gullberg H, Rudling M, Forrest D, Angelin B&Vennstrom B 2000 Thyroid hormone receptor β-deficient mice show complete loss of the normal cholesterol 7a-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Molecular Endocrinology 14 1739-1749. (doi:10.1210/mend.14.11.0548)
46. Gullberg H, Rudling M, Salto C, Forrest D, Angelin B&Vennstrom B 2002 Requirement for thyroid hormone receptor b in T3 regulation of cholesterol metabolism in mice. Molecular Endocrinology 16 1767-1777. (doi:10.1210/me.2002-0009)
47. Hackenmueller SA, Marchini M, Saba A, Zucchi R&Scanlan TS 2012 Biosynthesis of 3 iodothyronamine (T1AM) is dependent on the sodium-iodide symporter and thyroperoxidase but does not involve extrathyroidal metabolism of T4. Endocrinology 153 5659-5667. (doi:10.1210/en.2012-1254)
48. Hart ME, Suchland KL, Miyakawa M, Bunzow JR, Grandy DK&Scanlan TS 2006 Trace amine-associated receptor agonists; synthesis and evaluation of thyronamines and related analogues. Journal of Medicinal Chemistry 49 1101-1112. (doi:10.1021/jm0505718)
49. Hoefig CS, Köhrle J, Brabant G, Dixit K, Yap J, Strasburger CJ&Wu Z 2011 Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay. Journal of Clinical Endocrinology and Metabolism 98 1864-1872. (doi:10.1210/jc.2010-2680)
50. Hoefig CS, Renko K, Piehl S, Scanlan TS, Bertoldi M, Opladen T, Hoffmann GF, Klein J, Blankenstein O, Schweizer U et al. 2012 Does the aromatic L-amino acid decarboxylase contribute to thyronamine biosynthesis? Molecular and Cellular Endocrinology 349 195-201. (doi:10.1016/j.mce.2011.10.024)
51. Horn S, Kersseboom S, Mayerl S, Müller J, Groba C, Trajkovic-Arsic M, Ackermann T, Visser TJ&Heuer H 2013 Tetrac can replace thyroid hormone during brain development in mouse mutants deficient in the thyroid hormone transporter mct8. Endocrinology 154 968-679. (doi:10.1210/en.2012-1628)
52. Ianculescu AG, Giacomini KM&Scanlan TS 2009 Identification and characterization of 3-iodothyronamine intracellular transport. Endocrinology 150 1991-1999. (doi:10.1210/en.2008-1339)
53. Ianculescu AG, Friesema EC, Visser TJ, Giacomini KM&Scanlan TS 2010 Transport of thyroid hormones is selectively inhibited by 3-iodothyronamine. Molecular BioSystems 6 1403-1410. (doi:10.1039/b926588k)
54. Incerpi S, De Vito P, Luly P, Spagnuolo S&Leoni S 2002 Short-term effects of thyroid hormones and 3,5-diiodothyronine on membrane transport systems in chick embryo hepatocytes. Endocrinology 143 1660-1668. (doi:10.1210/endo.143.5.8767)
55. Incerpi S, Scapin S, D'Arezzo S, Spagnuolo S&Leoni S 2005 Short-term effects of thyroid hormone in prenatal development and cell differentiation. Steroids 70 434-443. (doi:10.1016/j.steroids.2005.02.009)
56. Irrcher I, Walkinshaw DR, Sheehan TE&Hood DA 2008 Thyroid hormone (T3) rapidly activates p38 and AMPK in skeletal muscle in vivo. Journal of Applied Physiology 104 178-185. (doi:10.1152/japplphysiol.00643.2007)
57. Johansson L, Rudling M, Scanlan TS, Lundasen T, Webb P, Baxter J, Angelin B&Parini P 2005 Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. PNAS 102 10297-10302. (doi:10.1073/pnas.0504379102)
58. Klieverik LP, Foppen E, Ackermans MT, Serlie MJ, Sauerwein HP, Scanlan TS, Grandy DK, Fliers E&Kalsbeek A 2009 Central effects of thyronamines on glucose metabolism in rats. Journal of Endocrinology 201 377-386. (doi:10.1677/JOE-09-0043)
59. Kunitake JM, Hartman N, Henson LC, Lieberman J, Williams DE, Wong M & Hershman JM 1989 3,5,30-Triiodothyroacetic acid therapy for thyroid hormone resistance. Journal of Clinical Endocrinology and Metabolism 69 461-466. (doi:10.1210/jcem-69-2-461)
60. Ladenson PW 2011 Thyroid hormone analogues: ready for prime time. Thyroid 21 101-102. (doi:10.1089/thy.2010.2100.com1)
61. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliot P et al. 2006 Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127 1109-1122.
62. Lanni A, Moreno M, Cioffi M&Goglia F 1992 Effect of 3,30-diiodothyronine and 3,5-diiodothyronine on rat liver oxidative capacity. Molecular and Cellular Endocrinology 86 143-148. (doi:10.1016/0303-7207(92)90138-V)
63. Lanni A, Moreno M, Cioffi M&Goglia F 1993 Effect of 3,30-diiodothyronine and 3,5-di-iodothyronine on rat liver mitochondria. Journal of Endocrinology 136 59-64. (doi:10.1677/joe.0.1360059)
64. Lanni A, Moreno M, Horst C, Lombardi A&Goglia F 1994 Specific binding sites for 3,30-diiodo-L-thyronine (3,30-T2) in rat liver mitochondria. FEBS Letters 351 237-240. (doi:10.1016/0014-5793(94)00840-X)
65. Lanni A, Moreno M, Lombardi A&Goglia F 1996 Calorigenic effect of diiodothyronines in the rat. Journal of Physiology 494 831-837.
66. Lanni A, Moreno M, Lombardi A&Goglia F 1998 3,5-Diiodo-L-thyronine and 3,5,30-triiodo-L-thyronine both improve the cold tolerance of hypothyroid rats, but possibly via differentmechanisms. Pflügers Archiv: European Journal of Physiology 436 407-414. (doi:10.1007/s004240050650)
67. Lanni A, Moreno M, Lombardi A, de Lange P, Silvestri E, Ragni M, Farina P, Chieffi Baccari G, Fallahi P, Antonelli A et al. 2005 3,5-Diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB Journal 19 1552-1554.
68. Leary SC, Barton KN&Ballantyne JS 1996 Direct effects of 3,5,30-triiodothyronine and 3,5-diiodothyronine on mitochondrial metabolism in the goldfish Carassius auratus. General and Comparative Endocrinology 104 61-66. (doi:10.1006/gcen.1996.0141)
69. Lerman J 1956 The activity of dl-tribromthyronine. Journal of Clinical Endocrinology and Metabolism 16 1395-1397. (doi:10.1210/jcem-16-10-1395)
70. Lin HY, Sun M, Lin C, Tang HY, London D, Shih A, Davis FB&Davis PJ 2009a Androgen induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-a-positive and -negative breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 113 182-188. (doi:10.1016/j.jsbmb.2008.12.010)
71. LinHY, SunM, TangHY, LinC, LuidensMK, MousaSA, Incerpi S, DrusanoGL, Davis FB&Davis PJ 2009b L-Thyroxine vs. 3,5,3-triiodo-L-thyronine and cell proliferation: activation ofmitogen-activated protein kinase and phosphatidylinositol 3-kinase. American Journal of Physiology. Cell Physiology 296 C980-C991. (doi:10.1152/ajpcell.00305.2008)
72. Little AG, Kunisue T, Kannan K&Seebacher F 2013 Thyroid hormone actions are temperature-specific and regulate thermal acclimation in zebrafish (Danio rerio). BMC Biology 26 11-26. (doi:10.1186/1741-7007-11-26)
73. Lombardi A, De Matteis R, Moreno M, Napolitano L, Busiello RA, Senese R, de Lange P, Lanni A&Goglia F 2012 Responses of skeletal muscle lipid metabolism in rat gastrocnemius to hypothyroidism and iodothyronine administration: a putative role for FAT/CD36. American Journal of Physiology. Endocrinology and Metabolism 303 E1222-E1233. (doi:10.1152/ajpendo.00037.2012)
74. Luongo C, Trivisano L, Alfano F&Salvatore D 2013 Type 3 deiodinase and consumptive hypothyroidism: a common mechanism for a rare disease. Frontiers in Endocrinology 115 1-7. (doi:10.3389/fendo.2013.00115)
75. Maia AL, Goemann IM, Meyer EL&Wajner SM 2011 Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. Journal of Endocrinology 209 283-297. (doi:10.1530/JOE-10-0481)
76. Mangiullo R, Gnoni A, Damiano F, Siculella L, Zanotti F, Papa S & Gnoni GV 2010 3,5-Diiodo-L-thyronine upregulates rat-liver mitochondrial F(o)F(1)-ATP synthase by GA-binding protein/nuclear respiratory factor-2. Biochimica et Biophysica Acta 1797 233-240. (doi:10.1016/j.bbabio.2009.10.009)
77. Manni ME, De Siena G, Saba A, MarchiniM, Dicembrini I, Bigagli E, Cinci L, Lodovici M, Chiellini MG, Zucchi R et al. 2012 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice. British Journal of Pharmacology 166 650-658. (doi:10.1111/j.1476-5381.2011.01823.x)
78. Manni ME, De Siena G, Saba A, Marchini M, Landucci E, Gerace E, Zazzeri M, Mussili C, Pellegrini-Giampietro D, Matucci R et al. 2013 Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation and memory acquisition and retention and reduction of pain threshold. British Journal of Pharmacology 168 354-362. (doi:10.1111/j.1476-5381.2012.02137.x)
79. Medina-Gomez G, Hernandez A, Calvo RM, Martin E&Obregon MJ 2003 Potent thermogenic action of triiodothyroacetic acid in brown adipocytes. Cellular and Molecular Life Sciences 60 1957-1967. (doi:10.1007/s00018-003-3158-9)
80. Medina-Gomez G, Calvo MR&Obregon MJ 2004 T3 and Triac inhibit leptin secretion and expression in brown and white rat adipocytes. Biochimica et Biophysica Acta 1682 38-47. (doi:10.1016/j.bbalip.2004.01.007)
81. Mendoza A, Navarrete-Ramírez P, Hernández-Puga G, Villalobos P, Holzer G, Renaud JP, Laudet V&Orozco A 2013 3,5-T2 is an alternative ligand for the thyroid hormone receptor b1. Endocrinology 154 2948-2958. (doi:10.1210/en.2013-1030)
82. Moeller LC&Broecker-Preuss M 2011 Transcriptional regulation by nonclassical action of thyroid hormone. Thyroid Research 4(Suppl 1) S6. (doi:10.1186/1756-6614-4-S1-S6)
83. Moeller LC, Dumitrescu AM&Refetoff S 2005 Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1 and glycolytic genes. Molecular Endocrinology 19 2955-2963. (doi:10.1210/me.2004-0542)
84. Mollica MP, Lionetti L, Moreno M, Lombardi A, de Lange P, Antonelli A, Lanni A, Cavaliere G, Barletta A&Goglia F 2009 3,5-Diiodo-Lthyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. Journal of Hepatology 51 363-370. (doi:10.1016/j.jhep.2009.03.023)
85. Moreno M, Kaptein E, Goglia F&Visser TJ 1994 Rapid glucuronidation of tri- and tetraiodothyroacetic acid to ester glucuronides in human liver and to ether glucuronides in rat liver. Endocrinology 135 1004-1009. (doi:10.1210/endo.135.3.8070342)
86. Moreno M, Lombardi A, Beneduce L, Silvestri E, Pinna G, Goglia F & Lanni A 2002 Are the effects of T3 on resting metabolic rate in euthyroid rats entirely caused by T3 itself? Endocrinology 143 504-510. (doi:10.1210/endo.143.2.8613)
87. Moreno M, Silvestri E, De Matteis R, de Lange P, Lombardi A, Glinni D, Senese R, Cioffi F, Salzano AM, Scaloni A et al. 2011 3,5-Diiodo-Lthyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. FASEB Journal 25 3312-3324. (doi:10.1096/fj.11-181982)
88. Navarrete-Ramirez P, Luna M, Valverde RC&Orozco A 2014 3,5-T2 stimulates tilapia growth through an alternate isoform of thyroid hormone receptor b1. Journal of Molecular Endocrinology 52 1-9. (doi:10.1530/JME-13-0145)
89. Oetting A&Yen PM 2007 New insights into thyroid hormone action. Best Practice&Research. Clinical Endocrinology&Metabolism 21 193-208. (doi:10.1016/j.beem.2007.04.004)
90. Orozco A, Valverde RC, Olvera A&García GC 2012 Iodothyronine deiodinases: a functional and evolutionary perspective. Journal of Endocrinology 215 207-219. (doi:10.1530/JOE-12-0258)
91. Pascual A&Aranda A 2013 Thyroid hormone receptors, cell growth and differentiation. Biochimica et Biophysica Acta 1830 3908-3916. (doi:10.1016/j.bbagen.2012.03.012)
92. Piehl S, Heberer T, Balizs G, Scanlan TS, Smits R, Koksch B&Köhrle J 2008 Thyronamines are isozyme-specific substrates of deiodinases. Endocrinology 149 3037-3045. (doi:10.1210/en.2007-1678)
93. Pinna G, Meinhold H, Hiedra L, Thoma R, Hoell T, Gräf KJ, Stoltenburg-Didinger G, Eravci M, Prengel H, Brödel O et al. 1997 Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors. Journal of Clinical Endocrinology and Metabolism 82 1535-1542. (doi:10.1210/jcem.82.5.3939)
94. Pittman CS, Shimizu T, Burger A&Chambers JB Jr 1980 The nondeiodinative pathways of thyroxine metabolism: 3,5,30,5-tetraiodothyroacetic acid turnover in normal and fasting human subjects. Journal of Clinical Endocrinology and Metabolism 50 712-716. (doi:10.1210/jcem-50-4-712)
95. Pramfalk C, Pedrelli M&Parini P 2011 Role of thyroid receptor b in lipid metabolism. Biochimica et Biophysica Acta 1812 929-937. (doi:10.1016/j.bbadis.2010.12.019)
96. Rochira A, Damiano F, Marsigliante S, Gnoni GV&Siculella L 2013 3,5-Diiodo-l-thyronine induces SREBP-1 proteolytic cleavage block and apoptosis in human hepatoma (Hepg2) cells. Biochimica et Biophysica Acta 1831 1679-1688.
97. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM&Puigserver P 2005 Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434 113-118.
98. Ruderman NB, Carling D, Prentki M&Cacicedo 2013 AMPK, insulin resistance, and the metabolic syndrome. Journal of Clinical Investigation 123 2764-2772.
99. Saba A, Chiellini G, Frascarelli S, Marchini M, Chelardoni S, Rafaelli A, Tonacchera M, Vitti P, Scanlan TS&Zucchi R 2010 Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151 5063-5073. (doi:10.1210/en.2010-0491)
100. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S et al. 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nature Medicine 10 638-642. (doi:10.1038/nm1051)
101. Scapin S, Leoni S, Spagnuolo S, FioreAM&Incerpi S 2009 Short-term effects of thyroid hormones on NaC-KC-ATPase activity of chick embryo hepatocytes during development: focus on signal transduction. American Journal of Physiology. Cell Physiology 296 C4-C12. (doi:10.1152/ajpcell.90604.2007)
102. 3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the α- and β-forms for the acetic acid analog and failure of the human testis and kidney α-2 products to bind T3. Molecular Endocrinology 4 227-234. (doi:10.1210/mend-4-2-227)
103. Shang G, Gao P, Zhao Z, Chen Q, Jiang T, Zhang N&Li H 2013 3,5-Diiodo-L-thyronine ameliorates diabetic nephropathy in streptozotocininduced diabetic rats. Biochimica et Biophysica Acta 1832 674-684.
104. Sherman SI&Ladenson PW 1992 Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effects. Journal of Clinical Endocrinology and Metabolism 75 901-905. (doi:10.1210/jcem.75.3.1517383)
105. Shoemaker TJ, Kono T, Mariash CN&Evans-Molina C 2012 Thyroid hormone analogues for the treatment of metabolic disorders: new potential for unmet clinical needs? Endocrine Practice 18 954-964. (doi:10.4158/EP12086.RA)
106. Siegrist-Kaiser C&Burger AG 1994 Modification of the side chain of thyroid hormones. In Thyroid Hormone Metabolism, pp 17-198. Eds SY Wu&TJ Visser TJ. Boca Raton: CRC Press, Inc.
107. Siegrist-Kaiser CA, Juge-Aubry C, Tranter MP, Ekenbarger DM&Leonard JL 1990 Thyroxine-dependent modulation of actin polymerization in cultured astrocytes. A novel, extranuclear action of thyroid hormone. Journal of Biological Chemistry 265 5296-5302.
108. Silvestri E, Cioffi F, Glinni D, Ceccarelli M, Lombardi A, de Lange P, Chambery A, Severino V, Lanni A, Goglia F et al. 2010 Pathways affected by 3,5-diiodo-L-thyronine in liver of high fat-fed rats: evidence from two-dimensional electrophoresis, blue-native PAGE, and mass spectrometry. Molecular BioSystems 6 2256-2271. (doi:10.1039/c0mb00040j)
109. Snead AN, Miyakawa M, Tan ES&Scanlan TS 2008 Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites. Bioorganic & Medicinal Chemistry Letters 18 5920-5922. (doi:10.1016/j.bmcl.2008.08.013)
110. Tan ES, Miyakawa M, Bunzow JR, Grandy DK&Scanlan TS 2007 Exploring the structure-activity relationship of the ethylamine portion of 3-iodothyronamine for rat and mouse trace amine-associated receptor 1. Journal of Medicinal Chemistry 50 2787-2798. (doi:10.1021/jm0700417)
111. Tan ES, Groban ES, Jacobson MP&Scanlan TS 2008 Toward deciphering the code to aminergic G protein-coupled receptor drug design. Chemistry&Biology 15 343-353. (doi:10.1016/j.chembiol.2008.03.004)
112. Tata JR 2013 The road to nuclear receptors of thyroid hormone. Biochimica et Biophysica Acta 1830 3860-3866.
113. Visser TJ 1990 Importance of deiodination and conjugation in the hepatic metabolism of thyroid hormone. In The Thyroid Gland, pp 255-283. Ed. MA Greer. New York: Raven Press.
114. Visser TJ 2013 Thyroid hormone transporters and resistance. Endocrine Development 24 1-10. (doi:10.1159/000343695)
115. Webb P 2010 Thyroid hormone receptor and lipid regulation. Current Opinion in Investigational Drugs 11 1135-1142.
116. Weitzel JM&Alexander Iwen K 2011 Coordination of mitochondrial biogenesis by thyroid hormone. Molecular and Cellular Endocrinology 342 1-7. (doi:10.1016/j.mce.2011.05.009)
117. Williams GR 2000 Cloning and characterization of two novel thyroid hormone receptor b isoforms. Molecular and Cellular Biology 20 8329-8342. (doi:10.1128/MCB.20.22.8329-8342.2000)
118. Wrutniak C, Cassar-Malek I, Marchal S, Rascle A, Heusser S, Keller JM, Fléchon J, Dauça M, Samarut J, Ghysdael J et al. 1995 A 43-kDa protein related to c-Erb Aa1 is located in the mitochondrial matrix of rat liver. Journal of Biological Chemistry 270 16347-16354. (doi:10.1074/jbc.270.27.16347)
119. Wrutniak-Cabello C, Casas F&Cabello G 2001 Thyroid hormone action in mitochondria. Journal of Molecular Endocrinology 26 67-77. (doi:10.1677/jme.0.0260067)
120. Zucchi R, Chiellini G, Scanlan TS&Grandy DK 2006 Trace amineassociated receptors and their ligands. British Journal of Pharmacology 149 967-978. (doi:10.1038/sj.bjp.0706948)